Mehmet Kocoglu

12PUBLICATIONS

82CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 03, 2026

Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.

|May 12, 2026

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

|Aug 28, 2025

Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.

Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko

|Jul 29, 2025

Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Edward Richardson, Clifton C Mo, Eleonora Calabretta

|Mar 15, 2025

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.

Rahul Banerjee, Alicia Richards, Shonali Midha

|Feb 18, 2025

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Doris K Hansen, Lauren C Peres, Danai Dima

Pageof 2

Frequent Collaborators

Surbhi Sidana

Joseph P McGuirk

Jack Khouri

Douglas W Sborov

Larry D Anderson

Charlotte Wagner

Danai Dima

Krina Patel

Peter Voorhees

James A Davis

Frequent Collaborators

Surbhi Sidana

Joseph P McGuirk

Jack Khouri

Douglas W Sborov